Biomechanical Parameters of Gait in Patients With Parkins... | NCT00139321

Studies
Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes

NCT00139321

Sponsor

Groupe Hospitalier Pitie-Salpetriere

Status

Terminated

Last Update Posted

Jan 8, 2013Estimated

Enrollment

110Estimated

Phase

Not Applicable

Conditions

Gait Disorders, Neurologic

Interventions

Force platform and electromyography

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2013

Overall Recruitment Status or Expanded Access Status

Terminated

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jun 2004

Primary Completion Date

Jul 2007Actual

Completion Date

Jul 2007Actual

First Submitted Date

Aug 30, 2005

First Submission Date that Met QC Criteria

Aug 30, 2005

First Posted Date

Aug 31, 2005Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 7, 2013

Last Update Posted Date

Jan 8, 2013Estimated

Sponsor/Collaborators Module

Responsible Party, by Official Title

Marie-laure Welter, MD, PhD, Groupe Hospitalier Pitie-SalpetrierePrincipal Investigator

Lead Sponsor

Groupe Hospitalier Pitie-SalpetriereOTHER

Collaborators

Name	Class
Institut National de la Santé Et de la Recherche Médicale, France	OTHER_GOV

Description Module

Brief Summary

Gait disorders and falls are frequent in patients with parkinsonian syndromes. In patients with Parkinson's disease (PD), these signs occurred later during the course of the disease in comparison to patients with other degenerative parkinsonian disorders. The pathophysiology of these symptoms are still not fully understood. Gait initiation challenges the balance control system as the body moves from an upright stable static posture to a continuously unstable gait. The aim of this study is to analyse the gait initiation process in patients with parkinsonian disorders.

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

110Estimated

Name	Type	Description	Arm Group Labels	Other Names
Force platform and electromyography	Device

Measure	Description	Time Frame
Biomechanical gait initiation parameters

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patients able to walk without assistance
Patients with Parkinson's disease or other degenerative parkinsonian syndromes (progressive supranuclear palsy [PSP], multiple system atrophy [MSA], corticobasal degeneration [CBD], etc.)

Exclusion Criteria:

Other parkinsonian syndromes
Dementia
Neuroleptic treatment

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

85 Years

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Yves Agid, MD, PhD	CIC-Pitié-Salpêtrière	Study Director

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere		Paris		75013	France

Condition Browse Module

MeSH Terms

ID	Term
D020233	Gait Disorders, Neurologic
D051346	Mobility Limitation
D020734	Parkinsonian Disorders
D010300	Parkinson Disease

Ancestor Terms

ID	Term
D009461	Neurologic Manifestations
D009422	Nervous System Diseases
D012816	Signs and Symptoms
D013568	Pathological Conditions, Signs and Symptoms

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D004576	Electromyography

Ancestor Terms

ID	Term
D004568	Electrodiagnosis
D019937	Diagnostic Techniques and Procedures
D003933	Diagnosis
D009213	Myography

Browse Leaves

Not provided

Browse Branches

Not provided